You are here: Industry Insights > cancer

News List

Rexahn & BioSense Enter License Agreement contractpharma
April 17, 2019
To advance the development and commercialization of RX-3117 for pancreatic cancer and other cancers in Greater China...
Qiagen launches first FGFR-based cancer diagnostic fiercebiotech
April 17, 2019
Alongside Janssen’s accelerated approval of Balversa as the first targeted therapy for metastatic bladder cancer, the FDA also greenlighted Qiagen’s companion diagnostic test to ...
FDA approves first targeted therapy for metastatic bladder cancer worldpharmanews
April 16, 2019
FDA approves first targeted therapy for metastatic bladder cancer.
High-dose vitamin D shows benefit in patients with advanced colorectal cancer worldpharmanews
April 16, 2019
High-dose vitamin D shows benefit in patients with advanced colorectal cancer...
The Classic “Miracle Drug” has “Fallen off the Miracle Path”? Still the “King” in the Cancer Prevention Field PharmaSources/Yefenghong
April 16, 2019
As one of the most commonly used and oldest drugs in the world, aspirin was originally synthesized by Bayer Company in 1897, and marketed two years later.
Pfizer to use Concerto HealthAI technology for cancer treatments pharmaceutical-technology
April 12, 2019
Pfizer has partnered with patient-centred research firm Concerto HealthAI to fast-track actionable patient insights for investigational and commercialised cancer therapies...
AstraZeneca and Daiichi Sankyo sign $6.9bn cancer drug development deal pharmaceutical-technology
April 11, 2019
AstraZeneca has entered a deal worth up to $6.9bn with Daiichi Sankyo to develop and commercialise cancer drug trastuzumab deruxtecan...
Researchers develop new vaccine to teach immune system to attack cancer pharmaceutical-technology
April 11, 2019
Researchers develop new vaccine to teach immune system to attack cancer.
BMS Opdivo/Yervoy recommended for untreated kidney cancer via Cancer Drugs Fund pharmafile
April 11, 2019
BMS Opdivo/Yervoy recommended for untreated kidney cancer via Cancer Drugs Fund.
Seattle Genetics and Astellas Announce Positive Topline Results from Pivotal Trial of Enfortumab Vedotin in Locally Advanced or Metastatic Urothelial Cancer drugs
April 11, 2019
BOTHELL, Wash. and TOKYO, March 28, 2019 /PRNewswire/ -- Seattle Genetics, Inc.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 87 88 Next page